A Double Blind Randomized Trial of Cediranib versus placebo in patients receiving Paclitaxel/Carboplatin Chemotherapy for the treatment of Advanced or Metastatic Non-Small Cell Lung Cancer
Study identifier:D8483C00002
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Other
Official Title
A Double Blind Randomized Trial of Cediranib versus placebo in patients receiving Paclitaxel/Carboplatin Chemotherapy for the treatment of Advanced or Metastatic Non-Small Cell Lung Cancer
Medical condition
Non-small Cell Lung Cancer
Phase
N/A
Healthy volunteers
-
Study drug
-
Sex
-
Actual Enrollment
-
Study type
Interventional
Age
-
Date
Study Start Date: 01 Feb 2009
Primary Completion Date: -
Study Completion Date: -
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
-
Sponsors
AstraZeneca
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|
